Willis Investment Counsel Merck & Co., Inc. Transaction History

Willis Investment Counsel

$1.44 Billion
Q1 2024

A detailed history of Willis Investment Counsel transactions in Merck & Co., Inc. stock. As of the latest transaction made, Willis Investment Counsel holds 231,045 shares of MRK stock, worth $28.6 Million. This represents 2.12% of its overall portfolio holdings.

Number of Shares

231,045

Previous 231,045 -0.0%

Holding current value

$28.6 Million

Previous $25.2 Million 21.03%

% of portfolio

2.12%

Previous 1.79%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$100.18 - $109.02 $70,126 - $76,314	-700 Reduced 0.3%	231,045 $25.2 Million
Q3 2023 Mar 07, 2024	BUY	$102.95 - $114.33 $10,295 - $11,433	100 Added 0.04%	231,745 $23.9 Million
Q3 2023 Oct 17, 2023	BUY	$102.95 - $114.33 $10,295 - $11,433	100 Added 0.04%	231,745 $23.9 Million
Q2 2023 Mar 07, 2024	SELL	$108.61 - $118.38 $26,066 - $28,411	-240 Reduced 0.1%	231,645 $26.7 Million
Q2 2023 Jul 11, 2023	SELL	$108.61 - $118.38 $26,066 - $28,411	-240 Reduced 0.1%	231,645 $26.7 Million

Q1 2023 Mar 07, 2024	BUY	$102.94 - $114.86 $86,469 - $96,482	840 Added 0.36%	231,885 $24.7 Million
Q1 2023 Apr 18, 2023	BUY	$102.94 - $114.86 $1.87 Million - $2.09 Million	18,204 Added 8.52%	231,885 $24.7 Million
Q4 2022 Jan 18, 2023	SELL	$87.44 - $112.11 $3.9 Million - $5 Million	-44,637 Reduced 17.28%	213,681 $0
Q3 2022 Oct 12, 2022	SELL	$84.53 - $94.96 $3.11 Million - $3.49 Million	-36,755 Reduced 12.46%	258,318 $22.2 Million
Q2 2022 Aug 08, 2022	SELL	$83.49 - $94.64 $4.45 Million - $5.04 Million	-53,300 Reduced 15.3%	295,073 $26.9 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $492,517 - $552,080	-6,700 Reduced 1.89%	348,373 $28.6 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $1.07 Million - $1.34 Million	14,773 Added 4.34%	355,073 $27.2 Million
Q3 2021 Nov 17, 2021	SELL	$71.68 - $78.83 $410,654 - $451,617	-5,729 Reduced 1.66%	340,300 $25.6 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $293,966 - $325,156	-4,181 Reduced 1.19%	346,029 $26.9 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $21,002 - $24,738	-305 Reduced 0.09%	350,210 $27 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $5.28 Million - $5.86 Million	73,600 Added 26.58%	350,515 $28.7 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $2.69 Million - $3.04 Million	-36,700 Reduced 11.7%	276,915 $23 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $22.5 Million - $25.5 Million	-318,815 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $106,381 - $147,449	-1,679 Reduced 0.52%	318,815 $24.5 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $467,109 - $527,078	-6,021 Reduced 1.84%	320,494 $29.1 Million
Q3 2019 Nov 15, 2019	SELL	$76.08 - $82.93 $2,206 - $2,404	-29 Reduced 0.01%	326,515 $27.5 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $4.78 Million - $5.58 Million	68,414 Added 26.5%	326,544 $27.4 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $4.34 Million - $4.95 Million	-62,370 Reduced 19.46%	258,130 $30.4 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $639,352 - $741,957	-9,800 Reduced 2.97%	320,500 $24.5 Million
Q3 2018 Nov 15, 2018	SELL	$57.69 - $67.84 $1.93 Million - $2.27 Million	-33,500 Reduced 9.21%	330,300 $23.4 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $3.54 Million - $4.16 Million	-69,700 Reduced 16.08%	363,800 $22.1 Million
Q1 2018 May 11, 2018	BUY	$50.96 - $59.23 $4.34 Million - $5.05 Million	85,213 Added 24.47%	433,500 $23.6 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $598,120 - $714,222	11,587 Added 3.44%	348,287 $19.6 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $19.8 Million - $21.3 Million	336,700	336,700 $21.6 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Willis Investment Counsel with notifications on news.

Account

Willis Investment Counsel Merck & Co., Inc. Transaction History